ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 393

$593K Total Retail Price of All Prescriptions

Rank: 44 out of 393

413 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 413 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,067 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
WARFARIN SODIUM 444 441 1 17
SIMVASTATIN 376 349 2 1
OMEPRAZOLE 368 351 3 6
LEVOTHYROXINE SODIUM 350 335 4 3
AMLODIPINE BESYLATE 278 256 5 4
DONEPEZIL HCL 196 184 6 34
HYDROCODONE-ACETAMINOPHEN 194 150 S3 7 5
LISINOPRIL 181 170 8 2
GABAPENTIN 179 126 9 15
METOPROLOL TARTRATE 169 159 10 9
FUROSEMIDE 168 155 11 8
NAMENDA 160 160 12 59
SERTRALINE HCL 158 143 13 28
LOVASTATIN 138 130 14 14
LOSARTAN POTASSIUM 136 130 15 12
CARVEDILOL 131 120 16 21
METFORMIN HCL 120 101 17 7
ATORVASTATIN CALCIUM 119 114 18 19
LANTUS 116 114 19 73
AZITHROMYCIN 111 107 20 35
METOPROLOL SUCCINATE 106 88 21 22
CLOPIDOGREL 102 100 22 33
MIRTAZAPINE 101 77 23 89
ATENOLOL 97 93 24 13
CITALOPRAM HBR 96 77 25 23
FINASTERIDE 96 92 25 60
ZOLPIDEM TARTRATE 95 91 27 11
TERAZOSIN HCL 94 94 28 38
PANTOPRAZOLE SODIUM 90 85 29 56
PLAVIX 89 84 30 51
FLUTICASONE PROPIONATE 87 78 31 27
CIPROFLOXACIN HCL 82 73 32 57
INSULIN SYRINGE 79 79 33 110
DIGOXIN 78 78 34 66
ALENDRONATE SODIUM 75 74 35 16
RISPERIDONE 70 54 36 75
POTASSIUM CHLORIDE 67 55 37 20
SPIRIVA 67 67 37 41
ESCITALOPRAM OXALATE 63 63 39 133
MORPHINE SULFATE ER 63 48 S2 39 48
TAMSULOSIN HCL 62 56 41 25
DIVALPROEX SODIUM 61 38 42 124
ACETAMINOPHEN-CODEINE 58 18 S3 43 145
BACLOFEN 57 0 44 79
HYDROCHLOROTHIAZIDE 57 55 44 10
ADVAIR DISKUS 57 57 44 53
LYRICA 56 56 47 119
QUETIAPINE FUMARATE 56 45 47 104
PRAVASTATIN SODIUM 55 43 49 18
AVODART 53 51 50 189
GLIPIZIDE 53 49 50 32
NOVOLIN R 51 51 52 144
PREDNISONE 50 49 53 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.